Table I.
Summary of demographic and clinical characteristics
| Patients | N = 18 n (%) |
|---|---|
| Age (d) | 55.5 (40-75) med (IQR) |
| Sex | 7 (39%) Male |
| Race | 12 (67%) Other |
| Ethnicity (self-reported) | 14 (78%) Latinx |
| Ct | 4.39 (3.24-6.53) med (IQR) |
| ED visit | 15 (83%) |
| Hospital admission | 9 (50%) |
| Fever at home | 14 (78%) |
| Fever at hospital | 9 (50%) |
| Nasal congestion, rhinorrhea | 5 (28%) |
| Cough | 8 (44%) |
| Gastrointestinal symptoms (vomiting, diarrhea) | 4 (22%) |
| Increased work of breathing | 1 (6%) |
| Poor feeding | 5 (28%) |
| Fussiness | 4 (22%) |
| Other symptoms | eye redness (n = 2), rash (n = 1), choking with feeds (n = 1) |
| Hypoxemia | 0 |
| CBC obtained | 12 (67%) |
| White blood cell count (thou/uL) | 8.3 (6.1-10.1) med (IQR) |
| Absolute neutrophil count (thou/uL) | 2639 (1590-4620) med (IQR) |
| Absolute lymphocyte count (thou/uL) | 3750 (2645-5007) med (IQR) |
| Hemoglobin (g/dL) | 11.35 (10.75-12.75) med (IQR) |
| Platelet count (thou/uL) | 351 (253-411) med (IQR) |
| Chest radiograph obtained | 5 (28%) initial visit, 1 follow-up ED visit |
| Intravenous fluids | 5 (28%) |
| Respiratory support | 0 |
| Intravenous antibiotics | 6 (33%) |
| Blood culture obtained | 12 (67%) |
| Urinalysis/urine culture obtained | 12 (67%) |
| Other viral PCR | 5 obtained and resulted negative (28%) |
| Extended family lives in home | 8 (44%) |
| Number of persons in home (including infant) | 5.2 (1.6) mean (SD) |
| Symptomatic contact | 14 (78%) |
| Confirmed COVID-19+ contact | 8 (44%) positive, 2 tests pending |
CBC, complete blood count.